Skip to content
RASFFReference 2020.3756

unauthorised substance Nicotinamide Mononucleotide (NMN) in food supplement

Official information organised for easier consultation. The source publication remains authoritative.

RASFF

Identification and classification

Reference
2020.3756
Notification ID
441604
Classification
information notification for follow-up
Risk decision
undecided
Product type
food
Notification basis
monitoring of media
Status
ec_validated

RASFF

Product

Description
NMN Nicotinamide mononucleotide
Distribution status
Description
product traded online
Notification ID
228
Notification ID
2659948
Category
Description
dietetic foods, food supplements and fortified foods
Notification ID
18439
Product descriptions
  1. Notification ID
    2660735

RASFF

Risk and analytical results

Notification ID
39822

RASFF

Origin, notification and distribution

Origin
United Kingdom
Notifying country or territory
Switzerland
Published distribution
product traded online

RASFF

Published territorial roles

  1. Roles
    1. Role
      NOTIFYING
      notificationId
      441604
    Organisation
    code
    CH
    countryNetworkOrganizationId
    5004
    Description
    Switzerland
    Notification ID
    63
  2. Roles
    1. Role
      FOR_FOLLOW_UP
      notificationId
      441604
    2. Role
      ORIGIN
      notificationId
      441604
    3. Role
      OPERATOR
      notificationId
      441604
    Organisation
    code
    GB
    countryNetworkOrganizationId
    5014
    Description
    United Kingdom
    Notification ID
    17

RASFF

Follow-ups

  1. fupDate
    24-09-2020 12:38:34
    fupId
    442682
    fupNumber
    1
    fupType
    Description
    notification upgrade
    Notification ID
    27667
    networkOrganizationId
    63
    organizationCode
    CH
    organizationDescription
    Switzerland

RASFF

Provenance and context

NagameAlert organises public RASFF data while preserving official values and keeping notification classification separate from the risk decision. The official record remains authoritative and should be checked for follow-ups and current status.